Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionSmall molecule inhibitor of EGFR, EGFR2 (HER2; ErbB2; neu) and EGFR3 (HER3; ErbB3)
Molecular Target Epidermal growth factor receptor (EGFR) ; Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Mechanism of ActionEpidermal growth factor (EGF) receptor 2 (HER2) (ErbB2) (neu) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationEsophageal cancer
Indication DetailsTreat advanced stomach and esophageal cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today